Literature DB >> 16368478

High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus.

Linda P DiPersio1, Joseph R DiPersio.   

Abstract

In vitro susceptibility testing on 200 Streptococcus agalactiae strains isolated during a 4-year period from vaginal/rectal specimens demonstrated a very high resistance rate for both erythromycin (54%) and clindamycin (33%). Methylase genes erm(B) and erm(TR) and efflux genes mef(E) and mef(A) were detected. Pulsed-field gel electrophoresis showed evidence of both clonal spread and multiclonal dissemination of resistant strains. All but 3 of 200 isolates were susceptible to telithromycin.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16368478     DOI： 10.1016/j.diagmicrobio.2005.07.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  18 in total

1.  High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.

Authors:  Ephraim E Back; Elisa J O'Grady; Joshua D Back
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Point prevalence study of antibiotic susceptibility of genital group B streptococcus isolated from near-term pregnant women in Calgary, Alberta.

Authors:  Deirdre Church; Julie Carson; Dan Gregson
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

3.  High rates of inducible clindamycin resistance among prenatal group B streptococcal isolates in one northwest Louisiana academic medical center.

Authors:  Gerald A Capraro; Ellen D Rambin; John A Vanchiere; Joseph A Bocchini; Janice M Matthews-Greer
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

4.  Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.

Authors:  Benjamin R Berg; Jeana L Houseman; Zachary E terSteeg; William D LeBar; Duane W Newton
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

5.  Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching.

Authors:  Mary Meehan; Robert Cunney; Mary Cafferkey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-28       Impact factor: 3.267

6.  Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease.

Authors:  Anne J Blaschke; Laurie S Pulver; E Kent Korgenski; Lucy A Savitz; Judy A Daly; Carrie L Byington
Journal:  J Pediatr       Date:  2010-01-13       Impact factor: 4.406

7.  Prevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus.

Authors:  Linda P DiPersio; Joseph R DiPersio; Kevin C Frey; Jacqueline A Beach
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

8.  Penicillin susceptibility and macrolide-lincosamide-streptogramin B resistance in group B Streptococcus isolates from a Canadian hospital.

Authors:  Kevin Sherman; Sue Whitehead; Edith Blondel-Hill; Ken Wagner; Naowarat Cheeptham
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

9.  Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.

Authors:  A Bergal; L Loucif; D E Benouareth; A A Bentorki; C Abat; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-28       Impact factor: 3.267

10.  Effect of subtherapeutic vs. therapeutic administration of macrolides on antimicrobial resistance in Mannheimia haemolytica and enterococci isolated from beef cattle.

Authors:  Rahat Zaheer; Shaun R Cook; Cassidy L Klima; Kim Stanford; Trevor Alexander; Edward Topp; Ron R Read; Tim A McAllister
Journal:  Front Microbiol       Date:  2013-05-27       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.